Department of Obstetrics and Gynecology, Maternal and Child Health Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Am J Perinatol. 2023 Dec;40(16):1781-1788. doi: 10.1055/s-0041-1739470. Epub 2021 Nov 28.
To determine if women who newly met criteria for stage 1 hypertension in early pregnancy were at increased risk for adverse perinatal outcomes compared with normotensive women.
We conducted a retrospective cohort study of women who had prenatal care at a single institution and subsequently delivered a live infant between December 2017 and August 2019. Women with a singleton gestation who had at least two prenatal visits prior to 20 weeks of gestation were included. We excluded women with known chronic hypertension or other major maternal illness. Two groups were identified: (1) women newly diagnosed with stage 1 hypertension before 20 weeks of gestation (blood pressure [BP]: 130-139/80-89 on at least two occasions) and (2) women with no known history of hypertension and normal BP (<130/80 mm Hg) before 20 weeks of gestation. The primary outcome was any hypertensive disorder of pregnancy; secondary outcomes were indicated preterm birth and small for gestational age. Generalized linear models were used to compare risk of adverse outcomes between the groups.
Of the 1,630 women included in the analysis, 1,443 women were normotensive prior to 20 weeks of gestation and 187 women (11.5%) identified with stage 1 hypertension. Women with stage 1 hypertension were at significantly increased risk for any hypertensive disorder of pregnancy (adjusted risk ratio [aRR]: 1.86, 95% confidence interval [CI]: 1.12-3.04) and indicated preterm birth (aRR: 1.83, 95% CI: 1.12-3.02). Black women and obese women with stage 1 hypertension were at increased for hypertensive disorder of pregnancy compared with white women and nonobese women, respectively (aRR: 1.32, 95% CI: 1.11-1.57; aRR: 1.69, 95% CI: 1.39-2.06).
These results provide insight about the prevalence of stage 1 hypertension and inform future guidelines for diagnosis and management of hypertension in pregnancy. Future research is needed to assess potential interventions to mitigate risk.
· Stage 1 hypertension increased risk for hypertensive disorders of pregnancy and indicated preterm birth.. · Among women with stage 1 hypertension, risk of severe preeclampsia was 2.6 times higher than normotensive women.. · Black and obese women with stage 1 hypertension were at additional risk for adverse outcomes..
确定在妊娠早期新符合 1 期高血压标准的女性与血压正常的女性相比,是否有发生不良围产期结局的风险增加。
我们进行了一项回顾性队列研究,纳入了在一家机构进行产前护理且在 2017 年 12 月至 2019 年 8 月期间分娩活婴的女性。纳入标准为:单胎妊娠,妊娠 20 周前至少有两次产前检查;排除标准为:已知慢性高血压或其他严重的母体疾病。将这些女性分为两组:(1)妊娠 20 周前新诊断为 1 期高血压的女性(血压:至少两次为 130-139/80-89mmHg);(2)妊娠 20 周前无已知高血压病史且血压正常(<130/80mmHg)的女性。主要结局为任何妊娠高血压疾病;次要结局为早产和小于胎龄儿。采用广义线性模型比较两组不良结局的风险。
在纳入分析的 1630 名女性中,1443 名女性在妊娠 20 周前血压正常,187 名(11.5%)女性被诊断为 1 期高血压。与血压正常的女性相比,患有 1 期高血压的女性发生任何妊娠高血压疾病的风险显著增加(校正风险比[aRR]:1.86,95%置信区间[CI]:1.12-3.04)和早产(aRR:1.83,95% CI:1.12-3.02)的风险增加。黑人女性和肥胖女性发生妊娠高血压疾病的风险较白人女性和非肥胖女性分别增加(aRR:1.32,95% CI:1.11-1.57;aRR:1.69,95% CI:1.39-2.06)。
这些结果提供了 1 期高血压的患病率信息,并为妊娠高血压的诊断和管理未来指南提供了信息。需要进一步的研究来评估减轻风险的潜在干预措施。
1 期高血压增加了妊娠高血压疾病和早产的风险。
患有 1 期高血压的女性发生重度子痫前期的风险是血压正常女性的 2.6 倍。
黑人女性和肥胖女性患有 1 期高血压的风险增加,与不良结局相关。